Press release -

Great interest in joint seminar between Vironova Biosafety and AsahiKASEI on virus safety and filtration

Vironova Biosafety’s offices will be buzzing with distinguished visitors this week. Together with AsahiKASEI bioprocess Vironova is hosting a joint seminar entitled “Virus safety and virus filtration of biopharmaceuticals.” The seminar will cover key considerations in validation of virus reduction. Applications using nanofiltration with robust virus removal will be discussed along with commonly used virus reduction steps.

AsahiKASEI is an established global market leader in virus filtration products and their Product Manager and Scientific Coordinator, Sebastian Teitz, will introduce virus filtration and talk about designing a virus filtration process.

Mathilda Sjöberg and Gustav Gilljam from Vironova Biosafety share their expert knowledge of sources of viral contamination and challenges in viral clearance respectively.

There’s been a great interest in the seminar and unfortunately attendance has reached a maximum but Vironova will organize similar seminars in the future.

Related links

Topics

  • Medical research

Categories

  • biosafety
  • vironova

Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.

The Vironova offering comprises:

  • Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis
  • Viral clearance testing performed in GLP and BSLIII certified laboratories
  • MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.

Contacts

Josefina Nilsson

Press contact CEO